Adjuvant therapy after resection of colorectal liver metastases: the predictive value of the MSKCC clinical risk score in the era of modern chemotherapy

Table 3 Multivariate analysis of factors associated with overall survival in patients who underwent potentially curative resection for colorectal cancer liver metastases

Variable	Comparison	Hazard ratio	95% CI	PValue
Age	-	1.01	0.99 – 1.03	0.20
Distribution of metastasis	Bilobar vs. unilobar	1.68	1.18 – 2.39	0.004
MSKCC Clinical risk score	3-5 vs. 0-2	1.56	1.04 – 2.33	0.02
Initial stage of disease (UICC)				0.29
		Reference
	2	1.68	0.73 – 3.87	0.21
	3	1.88	0.85 – 4.18	0.11
	4	1.44	0.63 – 3.25	0.38
Adjuvant chemotherapy	Adjuvant CTx vs. no adjuvant CTx	0.69	0.49 – 0.98	0.04

ISSN: 1471-2407